concomitant occurrence of cemento-ossifying fibroma and adenomatoid odontogenic tumor with bilateral impacted permanent canines in the mandible

Clicks: 289
ID: 179357
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #64 of 150 articles by views in Applied and environmental microbiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 150 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Adenomatoid odontogenic tumor (AOT) is an uncommon, benign and slow growing odontogenic tumor, which is usually located in an anterior region of the maxilla without pain. Cemento-ossifying fibroma (COF) is a relatively rare benign tumor of the jaw. Here we present 2 lesions presenting in unusual forms, follicular variant of AOT in the mandible and COF associated with impacted canine in the mandible, occurring concomitantly in the same patient. Both lesions presented classic histopathologic features.
Reference Key
prakash2012indianconcomitant Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;A Ravi Prakash;P Sreenivas Reddy;Rajanikanth;Radhika M Bavle
Journal Applied and environmental microbiology
Year 2012
DOI
10.4103/0970-9290.102255
URL
http://www.ijdr.in/article.asp?issn=0970-9290;year=2012;volume=23;issue=3;spage=434;epage=435;aulast=Prakash
Keywords
mandible calcifications

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.